ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学会発表・講演等
  2. ポスター発表

Carbon ion radiotherapy for Unresectable Spinal and Paraspinal Sarcomas

https://repo.qst.go.jp/records/70989
https://repo.qst.go.jp/records/70989
bab5b7a9-8f66-4468-9a77-c9a1f6e6fc75
Item type 会議発表用資料 / Presentation(1)
公開日 2012-11-21
タイトル
タイトル Carbon ion radiotherapy for Unresectable Spinal and Paraspinal Sarcomas
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_c94f
資源タイプ conference object
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Imai, Reiko

× Imai, Reiko

WEKO 697769

Imai, Reiko

Search repository
Kamada, Tadashi

× Kamada, Tadashi

WEKO 697770

Kamada, Tadashi

Search repository
Maruyama, Katsuya

× Maruyama, Katsuya

WEKO 697771

Maruyama, Katsuya

Search repository
今井 礼子

× 今井 礼子

WEKO 697772

en 今井 礼子

Search repository
鎌田 正

× 鎌田 正

WEKO 697773

en 鎌田 正

Search repository
丸山 克也

× 丸山 克也

WEKO 697774

en 丸山 克也

Search repository
抄録
内容記述タイプ Abstract
内容記述 Purpose: The standard treatment for spinal and paraspinal sarcomas has been en bloc resection. However those sarcomas involving or close to the spinal canal have been one of the most challenging for orthopedic surgeons. Due to the high linear energy transfer (LET) and the Bragg peak, carbon ion radiotherapy has been expected to be more effective and safe in the treatment for sarcomas than low-LET radiation like photons. We evaluated the effectiveness and safety of carbon ion radiotherapy in patients with spinal and paraspinal sarcoma not suitable for surgical resection.
Methods: Between Jun 1996 and February 2012, 100 cases with spinal and paraspinal sarcomas received carbon ion radiotherapy. Ages ranged from 12 to 84 (median 53 years). Forty nine spinal and 51 paraspianal sarcomas were included. Fifty nine patients had primary disease presentation, 25 patients with recurrent disease after surgery and 16 patients with metastases. Pathological types were as follows: chondrosarcoma in 20, osoteosarcoma in 17, chordoma in 12, MFH originated from soft tissue in 10, MPNST in 5. Carbon ion radiotherapy was delivered in 16 fractions over 4 weeks. Median total dose was 70.4GyE (range from 52.8 to 70.4GyE). Clinical target volumes ranged between 12 and 1259 cm3 (median 205 cm3).
Results: Median follow up time was 31 (range: 2-162) months for all patients and all living patients were followed more than 6 months. At 5 years, actuarial overall local control (LC) rate and overall survival (OS) rate were 75% and 51%, respectively. Twelve patients with spinal sarcoma including 8 high grade sarcomas and 18 patients with paraspinal sarcoma including 12 high grade sarcomas have survived for 5 years. Two patients experienced grade 3 spinal cord late reaction in this series.
Conclusions: Carbon ion radiotherapy is suggested to be an effective and safe treatment for spinal and paraspinal sarcoma patients, especially for whom surgical resection is not a viable option.
会議概要(会議名, 開催地, 会期, 主催者等)
内容記述タイプ Other
内容記述 CTOS 17th Annual Meeting
発表年月日
日付 2012-11-17
日付タイプ Issued
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 19:56:28.913030
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3